D.E. Shaw & Co
CVRX icon

D.E. Shaw & Co’s CVRx CVRX Stock Holding History

D.E. Shaw & Co’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Sell
11,229
-84,983
-88% -$622K ﹤0.01% 4280
2025
Q4 		$683K Buy
96,212
+19,763
+26% +$180K ﹤0.01% 3767
2025
Q3 		$617K Buy
76,449
+23,074
+43% +$173K ﹤0.01% 3749
2025
Q2 		$314K Buy
53,375
+23,179
+77% +$160K ﹤0.01% 3853
2025
Q1 		$369K Sell
30,196
-15,073
-33% -$213K ﹤0.01% 3662
2024
Q4 		$574K Sell
45,269
-13,790
-23% -$170K ﹤0.01% 3529
2024
Q3 		$520K Sell
59,059
-5,029
-8% -$45.7K ﹤0.01% 3681
2024
Q2 		$768K Buy
64,088
+44,769
+232% +$515K ﹤0.01% 3352
2024
Q1 		$352K Sell
19,319
-20,954
-52% -$496K ﹤0.01% 3655
2023
Q4 		$1.27M Buy
40,273
+20,842
+107% +$391K ﹤0.01% 2977
2023
Q3 		$295K Sell
19,431
-66,029
-77% -$1.09M ﹤0.01% 3622
2023
Q2 		$1.32M Buy
85,460
+61,258
+253% +$747K ﹤0.01% 2914
2023
Q1 		$226K Buy
24,202
+11,771
+95% +$156K ﹤0.01% 3855
2022
Q4 		$228K Buy
+12,431
New +$153K ﹤0.01% 4194
2022
Q2 		– Sell
-59,578
Closed -$357K – 5406
2022
Q1 		$357K Buy
+59,578
New +$481K ﹤0.01% 4565

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GP
GSK plc London $599M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's CVRX Position: Q1 2026 in Review

D.E. Shaw & Co reduced its CVRx (CVRX) stake by 88% in Q1 2026, selling an estimated $622K and leaving 11,229 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #4280.

D.E. Shaw & Co first reported a position in CVRX in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.32M in Q2 2023. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

  • D.E. Shaw & Co held 11,229 shares of CVRx worth $106K as of Q1 2026.
  • D.E. Shaw & Co sold 84,983 CVRx shares in Q1 2026, an estimated $622K.
  • CVRx made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4280 holding.
  • D.E. Shaw & Co first reported a position in CVRx in Q1 2022 and has held it in 15 quarters since.
  • D.E. Shaw & Co's CVRx position peaked at $1.32M in Q2 2023.
  • 99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.